Immunocore Holdings Plc (IMCR)
NASDAQ:IMCR
Want to see IMCR full AI Analyst Report?
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 297.57M | £ 247.98M | £ 197.39M | £ 144.23M | £ 27.04M |
| Gross Profit | £ 291.36M | £ 242.44M | £ 196.57M | £ 138.94M | £ 27.04M |
| Operating Income | £ -33.74M | £ -56.28M | £ -47.20M | £ -42.77M | £ -129.42M |
| EBITDA | £ 387.18K | £ -38.50M | £ -40.87M | £ -38.35M | £ -123.58M |
| Net Income | £ -26.42M | £ -40.81M | £ -43.75M | £ -43.46M | £ -133.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 864.15M | £ 820.38M | £ 350.27M | £ 402.47M | £ 321.06M |
| Total Assets | £ 1.07B | £ 1.01B | £ 472.44M | £ 526.76M | £ 407.28M |
| Total Debt | £ 43.56M | £ 432.72M | £ 66.50M | £ 81.45M | £ 86.16M |
| Net Debt | £ -424.15M | £ -23.01M | £ -283.77M | £ -321.02M | £ -234.90M |
| Total Liabilities | £ 686.24M | £ 648.79M | £ 180.55M | £ 187.86M | £ 175.76M |
| Stockholders' Equity | £ 381.03M | £ 360.72M | £ 291.89M | £ 338.90M | £ 231.53M |
| Cash Flow | |||||
| Free Cash Flow | £ -11.20M | £ 20.89M | £ -1.97M | £ -51.41M | £ -144.49M |
| Operating Cash Flow | £ -7.97M | £ 26.06M | £ 2.33M | £ -49.21M | £ -143.11M |
| Investing Cash Flow | £ -12.16M | £ -355.13M | £ -4.29M | £ -2.20M | £ -1.28M |
| Financing Cash Flow | £ 9.20M | £ 343.88M | £ 27.18M | £ 145.44M | £ 288.19M |